Quick Summary
- Analysts project Q1 earnings per share of $6.05 with revenue reaching $9.76 billion, marking a 3.1% increase versus prior year
- Consensus rating stands at Buy with average price target of $736.24, suggesting approximately 11% potential upside from current ~$665 level
- Critical focus area: profitability improvement, with segment operating margins anticipated to reach roughly 11%
- Notable developments include $475M Glide Phase Interceptor contract modification and successful YFQ-48A Talon Blue engine test
- Shares have declined 2% in the last month while the aerospace & defense industry rallied 10.3%
Northrop Grumman unveils its first quarter 2026 financial results Tuesday morning ahead of market open. Following an extended period of substantial development investments, market watchers are asking a critical question: has the profitability turnaround arrived?
Northrop Grumman Corporation, NOC
The Street anticipates earnings of $6.05 per share alongside sales of $9.76 billion. While these figures represent a sequential decline from the fourth quarter’s $7.23 EPS and $11.7 billion revenue, such patterns are typical. Defense industry companies generally deliver peak performance in their fiscal fourth quarters.
On an annual comparison basis, sales are projected to advance 3.1%. This would mark a significant turnaround from the 6.6% revenue contraction Northrop experienced in the first quarter of 2025.
During the previous quarter, the company exceeded expectations on both top and bottom lines. Sales reached $11.71 billion, climbing 9.6% year over year. Earnings per share landed at $7.23, surpassing the $6.99 Wall Street consensus. The only disappointment came from full-year earnings guidance, which fell short of analyst projections.
Shares currently trade in the $665–$667 range, positioned near the midpoint of the 52-week trading band spanning $450.13 to $774.00. Analyst price objectives have been trending upward. Wells Fargo launched coverage with a Buy recommendation and $800 price target on March 31. Deutsche Bank elevated its target to $778 on April 8. Jefferies adjusted its Hold-rated target upward to $710 on April 9.
Earnings projections have ticked up 0.51% during the past two months. Revenue forecasts have risen 0.24%. While modest, the trajectory points in a favorable direction.
Profitability Expansion Takes Priority
The primary question entering Tuesday’s announcement centers on whether margin improvement is materializing in actual financial results. Wall Street anticipates segment operating margins rebounding to approximately 11%.
The Aeronautics division benefits from cycling past a B-21 Raider development charge recorded last year, which should provide a boost. Mission Systems stands to gain from an improved program portfolio composition. Should both divisions perform as expected, it would indicate that Northrop’s capital-intensive development phase is reaching an inflection point.
Full-year earnings guidance remains another key consideration. Management’s current outlook spans $27.40 to $27.90. Analysts anticipate the company will maintain that range, though some believe the more compelling growth narrative unfolds in 2027.
New Contract Awards Shape Context
Northrop has experienced an active April regarding contract announcements. The defense giant secured a $475 million contract modification to expedite its Glide Phase Interceptor initiative. Its YFQ-48A Talon Blue autonomous combat platform successfully completed initial engine testing on April 17. Meanwhile, the Sentinel ICBM program continues progressing toward an inaugural flight scheduled for 2027.
NOC shares have retreated roughly 2% during the past thirty days. The wider aerospace and defense industry has gained 10.3% over the identical timeframe, positioning Northrop among the sector’s laggards approaching its quarterly report.
Industry competitors have begun releasing their results. AAR delivered 24.6% revenue expansion and exceeded projections, with shares surging 9.9%. Byrna achieved 10.9% growth but fell short of expectations, plunging 38.3%.
Analysts have maintained relatively stable estimates throughout the previous month, indicating no major positive or negative surprises are anticipated.





